Tags : Luca Dal Molin

Capital Markets

Homburger advises VectivBio on its USD 125m underwritten offering of

VectivBio Holding, a clinical-stage biopharmaceutical company pioneering novel transformational treatments for severe rare conditions, has announced the pricing of a USD 125 m underwritten offering of ordinary shares. The underwritten offering consists of 16,700,000 ordinary shares at an offering price of USD 7.50 per share. Investors include Cowen Healthcare Investments, Driehaus Capital Management, Eventide Asset […]

Deal & transactions IP Tax

Homburger advises Solenis on the acquisition of Kolb Distribution

Solenis has entered into a definitive agreement to acquire Kolb Distribution‘s paper process chemicals business, a unit of KLK Kolb Group. The deal includes a long-term supply agreement, in which the KLK Kolb Group will manufacture paper process chemicals exclusively for Solenis. The acquisition will expand Solenis’ product offering and provide long-term supply agreement for […]

Deal & transactions

Homburger advises BlackFin Capital Partners on the sale of New

BlackFin Capital Partners has reported the sale of its portfolio company New Access, a Geneva-based private banking technology firm, to FNZ, a global wealth management platform with registered office in London. The acquisted New Access is primarily active in the markets of Switzerland, Liechtenstein and Luxembourg. These markets are key to serving and administering client wealth globally […]

Banking & Finance

SonarSource raises USD 4.7bn in its growth equity financing

SonarSource, a platform for clean code, has completed a growth equity financing by General Catalyst, Advent International, Insight Partners, and Permira’s Growth Opportunities Fund.   The financing raised USD 412 million in new investment and values SonarSource at USD 4.7 billion. SonarSource will use the investment to grow its go-to-market team globally as the company drives […]

Banking & Finance

Homburger: VectivBio loan agreement of upto USD75 m with Kreos

VectivBio, a clinical-stage biotechnology company developing transformational medicines for patients with serious rare diseases, has entered into a loan agreement with Kreos Capital, a global growth lender to life sciences and healthcare companies, granting VectivBio access to a up to USD 75 m flexible loan facility. Homburger advised VectivBio with regard to all Swiss legal […]

Deal & transactions

CSL Limited public tender offer to acquire Vifor Pharma. The

CSL Limited, a global biotechnology company based in Australia and Vifor Pharma, a Swiss-based global pharmaceutical company, entered into an agreement for CSL to launch an all-cash public tender offer to acquire all publicly held shares in Vifor for USD 179.25 per share, for an aggregate equity value for Vifor of USD 11.7 billion. Vifor’s […]

Deal & transactions

Jenoptik acquires Berliner Glas Medical and SwissOptic from Asml

Asml Holding has agreed to sell a 100% stake in BG Medical Applications, SwissOptic and SwissOptic Co., to Jenoptik. BG Medical Applications is a supplier of high-precision, custom optical components for the medical technology sector based in Berlin, Germany. SwissOptic is a specialist in the development and manufacturing of optical components and assemblies, primarily for […]

Banking & Finance Capital Markets

Homburger advised Credit Suisse in the tokenization of Alaïa’s shares

Homburger acted as counsel to Credit Suisse (Switzerland) regarding the tokenization of Alaïa’s existing (registered) shares and the custody of the tokenized shares. Alaïa is one of the fastest growing action sports destinations in Europe. The tokenisation was effected under Swiss law, in conformity with the Capital Markets and Technology Association («CMTA»)’s standards, using the […]